作者：
Silke,Schelenz [1]
;
Samir,Agrawal [2]
;
Aaron,Brady [3]
;
Gillian,Kiely [4]
;
Zeshan,Riaz [4]
;
Emilie,Howes [4]
;
Tim,Felton [5]
;
Christianne,Micallef [6]
;
Netta,Tyler [7]
;
Tihana,Bicanic [8]
;
P Lewis,White [9]
作者单位：
School of Immunology & Microbial Sciences, Kings College London, London, UK.
[1]
Haemato-Oncology, Barts Health NHS Trust, London, UK.;Blizard Institute, Immunobiology, Queen Mary University of London, London, UK.
[2]
School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK.;Pharmacy Department, Belfast City Hospital, Belfast Health & Social Care Trust, Belfast BT9 7AB, UK.
[3]
Pfizer Ltd, Speciality Care BU, Tadworth, Surrey, UK.
[4]
Division of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Manchester, UK.
[5]
School of Pharmacy, University of East Anglia, Norwich, UK.;Pharmacy Department, Cambridge University Hospitals, Cambridge CB2 0QQ, UK.
[6]
Pharmacy Department, Cambridge University Hospitals, Cambridge CB2 0QQ, UK.
[7]
Institute of Infection and Immunity, City St George's University of London, London SW17 0RE, UK.
[8]
Public Health Wales Mycology Reference Laboratory, UHW, Heath Park, Cardiff CF14 4XW, UK.
[9]
DOI
10.1093/jacamr/dlae209
PMID
39741653
发布时间
2025-02-08
换一批
换一批
